International Stem Cell Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ISCO Over the counter 8731 http://www.internationalstemcell.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for International Stem Cell Corp

International Stem Cell Corporation to Present Interim Clinical Results at the American Academy of Neurology - Apr 18th, 2018 6:30 am
International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results - Apr 10th, 2018 6:45 am
International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial - Mar 5th, 2018 6:30 am
Edison Issues Update On International Stem Cell (ISCO) - Jan 22nd, 2018 8:22 am
International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 - Dec 27th, 2017 6:39 am
International Stem Cell Corp (ISCO) CEO Andrey Semechkin Bought $3.3 million of Shares - Dec 8th, 2017 2:15 pm
International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial - Nov 13th, 2017 6:30 am
International Stem Cell Corporation Receives Key Stem Cell Patent in Australia - Oct 31st, 2017 7:00 am
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases - Oct 9th, 2017 6:30 am
International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 - Sep 18th, 2017 11:13 am